Cutting-edge treatment option for early-stage primary liver cancer
29 January 2026
Congratulations to A/Professor Colin Tang, Sir Charles Gairdner Hospital Radiation Oncology Consultant and Investigator, who recently presented at the Accuray Australasian Symposium on a cutting-edge treatment option for early-stage primary liver cancer.
Prof Tang said his work explores whether stereotactic ablative body radiotherapy (SABR) could offer a safer, more effective treatment option for people with early-stage liver cancer.
SABR is a highly precise form of radiation therapy that delivers high doses of radiation to tumours, while minimising damage to surrounding healthy tissue.An advanced robotic version of this technology is known as CyberKnife.
Sir Charles Gairdner Hospital is home to the only public CyberKnife system in Australia, which can automatically track a tumour as it moves during treatment.
Prof Tang said that this type of therapy shows strong potential for treating t...